Literature DB >> 4757506

The vascularisation of deep-vein thrombi and their fibrous residue: a post mortem angio-graphic study.

S Sevitt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4757506     DOI： 10.1002/path.1711110102

Source DB:  PubMed          Journal:  J Pathol        ISSN： 0022-3417            Impact factor:   7.996


× No keyword cloud information.
  7 in total

Review 1.  Endovascular Interventions for Acute and Chronic Lower Extremity Deep Venous Disease: State of the Art.

Authors:  Akhilesh K Sista; Suresh Vedantham; John A Kaufman; David C Madoff
Journal:  Radiology       Date:  2015-07       Impact factor: 11.105

2.  Arterial wall lesions after pulmonary embolism, especially ruptures and aneurysms.

Authors:  S Sevitt
Journal:  J Clin Pathol       Date:  1976-08       Impact factor: 3.411

3.  Endothelial progenitor cells overexpressing platelet derived growth factor-D facilitate deep vein thrombosis resolution.

Authors:  Haolong Zhang; Hailong Luo; Bo Tang; Yikuan Chen; Jian Fu; Jianming Sun
Journal:  J Thromb Thrombolysis       Date:  2021-10-20       Impact factor: 2.300

4.  The structure and growth of valve-pocket thrombi in femoral veins.

Authors:  S Sevitt
Journal:  J Clin Pathol       Date:  1974-07       Impact factor: 3.411

5.  Analysis of recanalization of deep venous thrombosis: a comparative study of patients treated with warfarin vs. rivaroxaban.

Authors:  Polyana Klomfass Piati; Aline Krampe Peres; Danielle Oliveira de Andrade; Mirela Andressa Jorge; Jeferson Freitas Toregeani
Journal:  J Vasc Bras       Date:  2019-06-17

Review 6.  Leukocytes and the natural history of deep vein thrombosis: current concepts and future directions.

Authors:  Prakash Saha; Julia Humphries; Bijan Modarai; Katherine Mattock; Matthew Waltham; Colin E Evans; Anwar Ahmad; Ashish S Patel; Sobath Premaratne; Oliver T A Lyons; Alberto Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03       Impact factor: 8.311

7.  Patients with high levels of circulating endothelial progenitor cells (EPC) following at least three months of anticoagulation for unprovoked venous thromboembolism (VTE) are at low risk of recurrent VTE-Results from the ExACT randomised controlled trial.

Authors:  Charlotte Bradbury; Tracey Buckley; Yong Zhong Sun; Peter Rose; David Fitzmaurice
Journal:  EClinicalMedicine       Date:  2019-11-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.